Latest Chronic lower respiratory diseases Stories

New research conducted in 10 European cities has estimated that 14% of chronic childhood asthma is due to exposure to traffic pollution near busy roads. The results are comparable to the burden associated with passive smoking: the World Health Organization estimates that between 4% and 18% of asthma cases in children are linked to passive smoking. The findings, published online today (22 March 2013) ahead of print in the European Respiratory Journal, come as the European Commission...

MISSISSAUGA, ON, March 22, 2013 /CNW/ - PATHOS is the largest real-world study to compare the effectiveness of two commonly prescribed inhaled corticosteroid and long-acting beta agonist (ICS/LABA) combination treatments for chronic obstructive pulmonary disease (COPD) with more than one year of patient follow-up.(1 )An analysis of PATHOS data shows that COPD patients treated with SYMBICORT(®) (budesonide/formoterol) are significantly less likely to suffer from COPD-related...

Alan McStravick for redOrbit.com – Your Universe Online The sudden onset of an asthma attack can be a frightening event. Asthmatics often experience a severe shortness of breath combined with coughing or wheezing and a tightening sensation in their lungs and chest. If you suffer from asthma, there is a chronic state of inflammation in your lungs. When this inflammation is paired with constriction of the airwaves and muscles in the chest, it is important to seek immediate relief, either...

redOrbit Staff & Wire Reports - Your Universe Online Researchers at the Brigham and Women’s Hospital (BWH) in Boston have discovered a molecule that controls cells responsible for decreasing airway inflammation in asthma patients, and their discovery could lead to new treatments for the millions of Americans that suffer from the disease. The molecule is known as lipoxin A4, and according to the researchers, it is responsible for resolving inflammation. It accomplishes this in two...

People with COPD, asthma, emphysema, bronchitis, CF, and lung transplants are using the Spiro PD Personal Spirometer to monitor their lung health and to get “baseline” readings to compare with peak allergy season. For more information, visit http://www.SpiroPD.com. Allentown, Pennsylvania (PRWEB) February 26, 2013 The recent blizzard in the Northeast notwithstanding, many areas of the U.S. have experienced a mild winter, with unseasonably warm weather. A mild winter can signify an...

Study identifies possible therapeutic target to treat asthma and COPD New research examines the role of PKC in airway smooth muscle contraction and raises the possibility that this enzyme could be a therapeutic target for treating asthma, COPD, and other lung diseases. In the lungs, pathological increases in the contraction of the smooth muscle cells (SMCs) lining airway walls—a process that decreases airflow—contribute to the chain of events leading to asthma and COPD, two common...

Company works with leading pharmaceutical organizations to advance asthma research PHILADELPHIA, Feb. 26, 2013 /PRNewswire/ -- The Intellectual Property & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, today announced the launch of MetaMiner(TM) Asthma, the latest industry-academic-government, disease-focused collaboration dedicated to advancing the understanding of pathological pathways that cause...

MOUNTAIN VIEW, Calif., Feb. 25, 2013 /PRNewswire/ -- PneumRx, Inc., a leader in interventional pulmonology, announced the first U.S. patients treated with PneumRx's Lung Volume Reduction Coils (LVRCs) for severe emphysema. Dr. Charlie Strange, of the Medical University of South Carolina, and Dr. Frank Sciurba, of the University of Pittsburgh and UPMC, treated the first US patients in the FDA-approved RENEW Study. The RePneu® LVRC, a minimally invasive medical implant designed to...

Data presented at the 2013 American Academy of Allergy, Asthma & Immunology Annual Meeting SAN ANTONIO, Feb. 23, 2013 /PRNewswire/ -- Boehringer Ingelheim presented today a new subset of data from the Phase III UniTinA-asthma(TM) program at the 2013 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in San Antonio, Texas. In prespecified subgroups from two paired clinical trials, tiotropium delivered once daily via the Respimat® inhaler improved lung...

Spiro PD Personal Spirometer supports four of the five critical steps to prevent flu transmission as the epidemic continues to affect people nationwide, particularly those with chronic lung conditions. For more information, visit http://www.SpiroPD.com. Allentown, PA (PRWEB) February 21, 2013 Many healthcare professionals consider the current flu epidemic the worst in years. It has posed a severe threat to people with chronic lung conditions like asthma and COPD who are particularly...